bisoprolol has been researched along with Hyperventilation in 2 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Hyperventilation: A pulmonary ventilation rate faster than is metabolically necessary for the exchange of gases. It is the result of an increased frequency of breathing, an increased tidal volume, or a combination of both. It causes an excess intake of oxygen and the blowing off of carbon dioxide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paolillo, S | 1 |
| Pellegrino, R | 1 |
| Salvioni, E | 1 |
| Contini, M | 1 |
| Iorio, A | 1 |
| Bovis, F | 1 |
| Antonelli, A | 1 |
| Torchio, R | 1 |
| Gulotta, C | 1 |
| Locatelli, A | 1 |
| Agostoni, P | 1 |
| Van De Ven, LL | 1 |
| Mouthaan, BJ | 1 |
| Hoes, MJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Impact of Respiratory Rehabilitation on Quality of Life, Measures by the SF-36 Score, in Patients With Hyperventilation Syndrome: Crossover, Prospective and Randomized Study[NCT04668638] | 40 participants (Anticipated) | Interventional | 2021-03-10 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for bisoprolol and Hyperventilation
| Article | Year |
|---|---|
Role of alveolar β2-adrenergic receptors on lung fluid clearance and exercise ventilation in healthy humans.
Topics: Adult; Bisoprolol; Carbazoles; Carvedilol; Exercise; Extracellular Fluid; Humans; Hyperventilation; | 2013 |
Treatment of the hyperventilation syndrome with bisoprolol: a placebo-controlled clinical trial.
Topics: Adult; Antihypertensive Agents; Bisoprolol; Cross-Over Studies; Double-Blind Method; Female; Humans; | 1995 |